P. Ouvry

749 total citations
31 papers, 499 citations indexed

About

P. Ouvry is a scholar working on Surgery, Internal Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, P. Ouvry has authored 31 papers receiving a total of 499 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Surgery, 19 papers in Internal Medicine and 7 papers in Pathology and Forensic Medicine. Recurrent topics in P. Ouvry's work include Diagnosis and Treatment of Venous Diseases (24 papers), Venous Thromboembolism Diagnosis and Management (19 papers) and Systemic Sclerosis and Related Diseases (6 papers). P. Ouvry is often cited by papers focused on Diagnosis and Treatment of Venous Diseases (24 papers), Venous Thromboembolism Diagnosis and Management (19 papers) and Systemic Sclerosis and Related Diseases (6 papers). P. Ouvry collaborates with scholars based in France, Canada and Belgium. P. Ouvry's co-authors include P. Desnos, C. Hamel-Desnos, François‐André Allaert, Jan-Christoph Wollmann, Jean‐Patrick Benigni, M. Schadeck, C. Debure, G Pillion, F Zuccarelli and H. Lévesque and has published in prestigious journals such as Journal of Thrombosis and Haemostasis, European Journal of Vascular and Endovascular Surgery and Dermatologic Surgery.

In The Last Decade

P. Ouvry

24 papers receiving 451 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. Ouvry France 8 440 365 160 80 29 31 499
F. Pannier-Fischer Germany 7 445 1.0× 356 1.0× 118 0.7× 65 0.8× 14 0.5× 9 470
Roshan Bootun United Kingdom 12 463 1.1× 393 1.1× 134 0.8× 136 1.7× 9 0.3× 33 525
Robert Wütschert Switzerland 8 252 0.6× 171 0.5× 100 0.6× 29 0.4× 10 0.3× 11 307
T. R. Cheatle United Kingdom 15 448 1.0× 334 0.9× 50 0.3× 86 1.1× 21 0.7× 35 531
Marzia Lugli Italy 10 440 1.0× 414 1.1× 41 0.3× 111 1.4× 3 0.1× 28 506
Oscar Maleti Italy 13 525 1.2× 488 1.3× 45 0.3× 136 1.7× 3 0.1× 30 588
Kirienko Ai Russia 13 374 0.8× 238 0.7× 50 0.3× 20 0.3× 8 0.3× 55 468
Maher Hamish United Kingdom 9 310 0.7× 240 0.7× 93 0.6× 76 0.9× 2 0.1× 17 367
M. Leon United Kingdom 9 387 0.9× 343 0.9× 48 0.3× 104 1.3× 6 0.2× 14 429
C M Backhouse United Kingdom 6 375 0.9× 207 0.6× 25 0.2× 32 0.4× 19 0.7× 9 494

Countries citing papers authored by P. Ouvry

Since Specialization
Citations

This map shows the geographic impact of P. Ouvry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Ouvry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Ouvry more than expected).

Fields of papers citing papers by P. Ouvry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Ouvry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Ouvry. The network helps show where P. Ouvry may publish in the future.

Co-authorship network of co-authors of P. Ouvry

This figure shows the co-authorship network connecting the top 25 collaborators of P. Ouvry. A scholar is included among the top collaborators of P. Ouvry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Ouvry. P. Ouvry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Galanaud, J.‐P., et al.. (2020). Compression stockings to prevent postthrombotic syndrome: Literature overview and presentation of the CELEST trial. Research and Practice in Thrombosis and Haemostasis. 4(8). 1239–1250. 4 indexed citations
3.
Risse, Jessie, P F Combes, D. Creton, et al.. (2020). Update of the SFMV (French society of vascular medicine) guidelines on the conditions and safety measures necessary for thermal ablation of the saphenous veins and proposals for unresolved issues. JMV-Journal de Médecine Vasculaire. 45(3). 130–146. 2 indexed citations
4.
Righini, Marc, Helia Robert‐Ebadi, Fréderic Glauser, et al.. (2019). Effect of anticoagulant treatment on pain in distal deep vein thrombosis: an ancillary analysis from the cactus trial. Journal of Thrombosis and Haemostasis. 17(3). 507–510. 8 indexed citations
5.
Quéré, I., Antoine Élias, Marie Elias, et al.. (2019). Questions non résolues sur la maladie thrombo-embolique veineuse. Consensus de la Société française de médecine vasculaire (SFMV). JMV-Journal de Médecine Vasculaire. 44(1). e1–e47.
6.
Quéré, I., Antoine Élias, Marie Elias, et al.. (2019). Unresolved questions on venous thromboembolic disease. Consensus statement of the French Society for Vascular Medicine (SFMV). JMV-Journal de Médecine Vasculaire. 44(1). 28–70. 5 indexed citations
7.
Pernod, Gilles, Antoine Élias, Isabelle Gouin, et al.. (2012). Questions – réponses sur l’utilisation du rivaroxaban pour le traitement de la maladie thromboembolique veineuse. Journal des Maladies Vasculaires. 37(6). 300–310. 5 indexed citations
8.
Ouvry, P., et al.. (2012). Compression veineuse et thrombose veineuse profonde. Enquête de pratique en médecine vasculaire. Journal des Maladies Vasculaires. 37(3). 140–145. 10 indexed citations
9.
Ouvry, P., François‐André Allaert, P. Desnos, & C. Hamel-Desnos. (2008). Efficacy of Polidocanol Foam versus Liquid in Sclerotherapy of the Great Saphenous Vein: A Multicentre Randomised Controlled Trial with a 2-year Follow-up. European Journal of Vascular and Endovascular Surgery. 36(3). 366–370. 68 indexed citations
10.
Hamel-Desnos, C., P. Ouvry, Jean‐Patrick Benigni, et al.. (2007). Comparison of 1% and 3% Polidocanol Foam in Ultrasound Guided Sclerotherapy of the Great Saphenous Vein: A Randomised, Double-Blind Trial with 2 Year-Follow-up. “The 3/1 Study”. European Journal of Vascular and Endovascular Surgery. 34(6). 723–729. 85 indexed citations
11.
Hamel-Desnos, C., et al.. (2003). Evaluation of the Efficacy of Polidocanol in the Form of Foam Compared With Liquid Form in Sclerotherapy of the Greater Saphenous Vein: Initial Results. Dermatologic Surgery. 29(12). 1170–1175. 154 indexed citations
12.
Guilhou, J J, C. Debure, B. Guillot, et al.. (1997). Benefit of a 2-Month Treatment with a Micronized, Purified Flavonoidic Fraction on Venous Ulcer Healing. PubMed. 17(1). 21–26. 23 indexed citations
13.
Guilhou, Jean‐Jacques, O. Dereure, P. Ouvry, et al.. (1997). Efficacy of Daflon 500 mg in Venous Leg Ulcer Healing: A Double-Blind, Randomized, Controlled Versus Placebo Trial in 107 Patients. Angiology. 48(1). 77–85. 83 indexed citations
14.
Ouvry, P., et al.. (1991). [Ultrasonography of the popliteal fossa. Survey of a small saphenous arteriole before sclerotherapy].. PubMed. 44(1). 69–75; discussion 75. 1 indexed citations
15.
Ouvry, P., et al.. (1991). [Distal obliterating arteriopathy of the lower limbs in a systemic disease. Treatment with normovolemic hemodilution. [Report of one case]].. PubMed. 16(4). 387–9. 1 indexed citations
16.
Ouvry, P., et al.. (1988). [Sclerotherapy of perforating veins. Technics, doses].. PubMed. 40(3). 633–41.
17.
Ouvry, P., et al.. (1982). The place of surgery in the treatment of primary varices of the short saphenous vein.. PubMed. 35(1). 317–26. 1 indexed citations
18.
Ouvry, P., et al.. (1980). [Sclerosing treatment of telangiectasis of the lower extremities].. PubMed. 32(4). 365–70. 5 indexed citations
19.
Ouvry, P., et al.. (1980). [Acquired telangiectases of the lower extremities].. PubMed. 32(4). 359–64. 1 indexed citations
20.
Ouvry, P.. (1976). [Association of Klippel-Trenaunay and Sturge-Weber syndromes].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 29(1). 39–45. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026